Literature DB >> 7367997

The effect of delta-aminolevulinic acid on the synthesis and metabolism of GABA in rabbit brain homogenates.

D M Becker, E Cayanis, S Kramer.   

Abstract

The porphyrin precursor delta-aminolevulinic acid (delta-ALA) is a structural analogue of the putative amino acid neurotransmitter, gamma-aminobutyric acid (GABA). This study has demonstrated that delta-ALA has no effect on glutamate decarboxylase activity and only a small inhibitory effect of GABA aminotransferase activity. This would suggest that if accumulation of delta-ALA is related to development of the acute attack of porphyria, it is not via an effect on GABA synthesis and metabolism.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7367997

Source DB:  PubMed          Journal:  S Afr Med J


  3 in total

1.  Homozygous hydroxymethylbilane synthase knock-in mice provide pathogenic insights into the severe neurological impairments present in human homozygous dominant acute intermittent porphyria.

Authors:  Makiko Yasuda; Lin Gan; Brenden Chen; Chunli Yu; Jinglan Zhang; Miguel A Gama-Sosa; Daniela D Pollak; Stefanie Berger; John D Phillips; Winfried Edelmann; Robert J Desnick
Journal:  Hum Mol Genet       Date:  2019-06-01       Impact factor: 6.150

2.  Increased delta aminolevulinic acid and decreased pineal melatonin production. A common event in acute porphyria studies in the rat.

Authors:  H Puy; J C Deybach; A Bogdan; J Callebert; M Baumgartner; P Voisin; Y Nordmann; Y Touitou
Journal:  J Clin Invest       Date:  1996-01-01       Impact factor: 14.808

3.  Are delta-aminolevulinate dehydratase inhibition and metal concentrations additional factors for the age-related cognitive decline?

Authors:  Marília Baierle; Mariele F Charão; Gabriela Göethel; Anelise Barth; Rafael Fracasso; Guilherme Bubols; Elisa Sauer; Sarah C Campanharo; Rafael C C Rocha; Tatiana D Saint'Pierre; Suelen Bordignon; Murilo Zibetti; Clarissa M Trentini; Daiana S Avila; Adriana Gioda; Solange C Garcia
Journal:  Int J Environ Res Public Health       Date:  2014-10-17       Impact factor: 3.390

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.